Real-world prevalence of endoscopic findings in patients with gastroesophageal reflux symptoms: a cross-sectional study

Abstract

Background and study aims Data regarding endoscopic findings and symptom correlation in patients with gastroesophageal reflux disease (GERD) symptoms are largely limited to single-center experiences. We performed a nationwide study to examine the association between patient-reported GERD symptoms and clinically relevant endoscopic findings.

Patients and methods Using the National Endoscopic Database, we retrospectively identified all esophagogastroduodenoscopies (EGDs) performed for GERD symptoms from 2000 to 2014. Patients were categorized into three symptom groups: 1) typical reflux only (R); 2) airway only (A); and 3) both R and A (R + A). Outcomes were the point prevalence of endoscopic findings in relation to patient-reported GERD symptom groups. Statistical analyses were performed using R.

Results A total of 167,459 EGDs were included: 96.8 % for R symptoms, 1.4 % for A symptoms, and 1.8 % for R + A symptoms. Of the patients, 13.4 % had reflux esophagitis (RE), 9.0 % Barrett’s esophagus (BE), and 45.4 % hiatal hernia (HH). The R + A group had a significantly higher point prevalence of RE (21.6 % vs. 13.3 % and 12 %; P < 0.005) and HH (56.9 % vs. 45.3 % and 38.3 %; P < 0.005) compared to the R or A groups, respectively. The R group had a significantly higher point prevalence of BE compared to the A or R + A groups, respectively (9.1 % vs. 6.1 % and 6.1 %, P < 0.005).

Conclusions On a national level, patients experiencing R + A GERD symptoms appear more likely to have RE and HH, while those with only R symptoms appear more likely to have BE. These real-world data may help guide how providers and institutions approach acid-suppression therapy, set thresholds for recommending EGD, and develop management algorithms.

Publikationsverlauf

Eingereicht: 19. März 2021

Angenommen nach Revision: 12. August 2021

Artikel online veröffentlicht:
14. April 2022

• References

• 1 Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001; 111: 1313-1317
• 2 Dulai GS, Guha S, Kahn KL. et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 2002; 122: 26-33
• 3 Nason KS, Murphy T, Schindler J. et al. A cross-sectional analysis of the prevalence of Barrett’s esophagus in otolaryngology patients with laryngeal symptoms. J Clin Gastroenterol 2013; 47: 762-768
• 4 Lundell LR, Dent J, Bennett JR. et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180
• 5 Moayyedi P, Talley NJ, Fennerty MB. et al. Can the clinical history distinguish between organic and functional dyspepsia?. JAMA 2006; 295: 1566-1576
• 6 Vakil N, van Zanten SV, Kahrilas P. et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1943
• 7 Vaezi MF. Atypical manifestations of gastroesophageal reflux disease. MedGenMed 2005; 7: 25
• 8 Grossi L, Ciccaglione AF, Marzio L. Typical and atypical symptoms of gastro esophageal reflux disease: Does Helicobacter pylori infection matter?. World J Gastrointest Pharmacol Ther 2015; 6: 238-243
• 9 Eatrides J, Tucci VT, Schrot R. The case of the infection that wasn't!. J Glob Infect Dis 2009; 1: 139-143
• 10 Rybak A, Pesce M, Thapar N. et al. Gastro-esophageal reflux in children. Int J Mol Sci 2017; 18: 1671
• 11 Fan X, Snyder N. Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender. Dig Dis Sci 2009; 54: 572-577
• 12 Modiano N, Gerson LB. Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag 2007; 3: 1035-1145
• 13 Hyun JJ, Bak YT. Clinical significance of hiatal hernia. Gut Liver 2011; 5: 267-277
• 14 Abdul-Hussein M, Freeman J, Castell DO. Cough and throat clearing: atypical GERD symptoms or not GERD at all?. J Clin Gastroenterol 2016; 50: e50-54
• 15 Vakil N, van Zanten SV, Kahrilas P. et al. The Montreal definition and classification of gastroesophageal reflux disease: a global, evidence-based consensus paper. Z Gastroenterol 2007; 45: 1125-1140
• 16 Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007; 56: 1654-1664
• 17 Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990; 141: 640-647
• 18 Lieberman D, Fennerty MB, Morris CD. et al. Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology 2004; 127: 1067-1075
• 19 Enestvedt BK, Gralnek IM, Mattek N. et al. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc 2008; 67: 422-429
• 20 Enestvedt BK, Gralnek IM, Mattek N. et al. Endoscopic therapy for peptic ulcer hemorrhage: practice variations in a multi-center U.S. consortium. Dig Dis Sci 2010; 55: 2568-2576